-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on LifeStance Health Gr, Raises Price Target to $9

Benzinga·08/08/2025 16:45:44
Listen to the news
UBS analyst Kevin Caliendo maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $8.5 to $9.